Diaphragm Weakness in Pulmonary Arterial Hypertension: Role of Sarcomeric Dysfunction

American Journal of Physiology - Lung Cellular and Molecular Physiology - United States
doi 10.1152/ajplung.00135.2012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Physiological Society

Related search

Metabolic Dysfunction in Pulmonary Arterial Hypertension

Current Hypertension Reports
Internal Medicine
2015English

Role of Oxidized Lipids in Pulmonary Arterial Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2016English

Pulmonary Arterial Hypertension

Current Problems in Cardiology
MedicineCardiovascular MedicineCardiology
2011English

Diaphragm Dysfunction in Chronic Obstructive Pulmonary Disease: A Role for Heparan Sulphate?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Epsin15 Homology Domains: Role in the Pathogenesis of Pulmonary Arterial Hypertension

Frontiers in Physiology
Physiology
2018English

Arrhythmias in Pulmonary Arterial Hypertension

Journal of Congenital Cardiology
2017English

Other Causes of Pulmonary Arterial Hypertension: Pulmonary Veno-Occlusive Disease, Pulmonary Capillary Hemangiomatosis, Porto-Pulmonary Hypertension, HIV- Associated Pulmonary Arterial Hypertension

Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology
2010English

Pulmonary Arterial Hypertension in Children

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

Trends in Pulmonary Arterial Hypertension

European Respiratory Review
PulmonaryRespiratory Medicine
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy